Trials / Sponsors / Jiping Wang, MD, PhD
Jiping Wang, MD, PhD
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | SIRT With Tremelimumab and Durvalumab for Resectable HCC Resectable Hepatocellular Carcinoma, Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 1 | 2023-04-21 |